Syncom Formulations (India) informs about closure of trading window

Syncom Formulations (India) Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524470 | NSE: SYNCOMF

01 Aug 2017 Evaluate

Syncom Formulations (India) has informed about pursuant to SEBI (PIT) Regulations, 2015, window for trading in the Shares of the Company shall remain closed from 5th August, 2017 to 15th August, 2017 in view of the Meeting of Board of Directors of the Company, which is scheduled to be held on Monday, 14th August, 2017 at 3:30 P.M. to consider and approve Unaudited Financial Results with Limited Review Report for the Quarter ended on 30th June, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1835.50
Dr. Reddys Labs.	1171.10
Cipla	1371.45
Lupin	2144.70
Zydus Lifesciences	1153.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.